FLT3 and acute myeloid leukemia: The present study has revealed the involvement of SHP2, which interacts with Gab2 phosphorylated by FLT3-ITD, in activation of the MEK/ERK pathway, as well as its negative feedback regulation by RSK in FLT3-ITD-positive AML cells (Figure 7).